Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Would you recommend hypofractionated PMRT with a positive deep margin?
How would you dose?
Answer from: Radiation Oncologist at Community Practice
I have used hypofractionated RT in this setting with final boost to area of positive margin equivalent to 60 Gy
Comments
Radiation Oncologist at Charlotte Hungerford Hospital
Thank you!
Radiation Oncologist at Bismarck Cancer Center
I agree, with a caveat - if the pathology report d...
Radiation Oncologist at Mallory Radiotherapy, PLLC
Dr. @Beriwal, what bolus regimen for the primary a...
Radiation Oncologist at Varian Medical Systems/Allegheny health network
If it’s a deep margin, then may avoid bolus ...
1396
1399
13525
13535
Sign in or Register to read more
5215
Related Questions
Given the 10-year outcomes of UK FAST-Forward presented at ESTRO, how have you expanded the use of ultra-hypofractionation in your practice?
Do you recommend adjuvant RT to patients with non-ATM genetic mutations (e.g. BRCA, NF) who elect to have lumpectomy and are otherwise PRIME II/CALGB candidates for RT omission (i.e. low risk disease characteristics: strongly ER+, <1cm, grade 1-2, no LVI, widely negative margins, and committed to endocrine therapy)?
What are your top takeaways in Radiation Oncology from SABCS 2024?
How would you approach the treatment of low grade, stage IA, triple negative apocrine adenocarcinoma of the breast in a female patient in her 70s?
What is your approach to women with breast cancer who opts for a staged approach with up-front lumpectomy and SLN biopsy (pN-) when there are indications for adjuvant radiation therapy but she plans for a later mastectomy (=>6 months)?
How would you approach reirradiation in a patient with a history of whole-breast RT many years ago, now with a small intermediate-grade DCIS s/p lumpectomy with an elevated DCISionRT?
When treating early stage breast cancer with adjuvant RT, what risk factors would lead you to include the level 1 and 2 axilla in patients with pN0(i+) disease?
Would you recommend MRI post surgery and pre-irradiation for patients with extensive DCIS and close margins and how would it impact your management?
Is it reasonable to extrapolate the findings of RT Charm and Alliance to intact breast patients and offer hypofractionated RNI to all patients who are eligible for RNI?
What is the appropriate approach to manage a patient with triple-negative, locally advanced breast cancer (LN+) who progresses on neoadjuvant chemo-immunotherapy (KEYNOTE-522 regimen)?
Thank you!
I agree, with a caveat - if the pathology report d...
Dr. @Beriwal, what bolus regimen for the primary a...
If it’s a deep margin, then may avoid bolus ...